Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[A symphony for the camptothecins].

Amélie Lansiaux¹, Christian Bailly

¹Laboratoire de pharmacologie antitumorale, Centre Oscar-Lambret, Unité 524 Inserm, place de Verdun, 59045 Lille.

Bulletin Du Cancer

|June 13, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Antifungal products and associated mechanisms of action in the fight against Didymella segeticola responsible for tea and tobacco leaf spot diseases.

Pesticide biochemistry and physiology·2026

Same author

Chlorophenylpyrazolone derivatives as novel PD-L1-targeted inhibitors of the PD-1/PD-L1 immune checkpoint.

Bioorganic & medicinal chemistry letters·2026

Same author

The known and unknown of wuyiencin: a potent natural product active against phytopathogenic fungi.

Biochemical pharmacology·2026

Same author

Experimental and MEDT Study of Sydnone-Alkyne Cycloaddition-Based Synthesis of 1,4-Disubstituted Pyrazoles and In Silico Investigation of Their Binding to HCV and HIV Proteins.

Molecules (Basel, Switzerland)·2026

Same author

The Chemistry and Pharmacology of the Alkaloid Barettin and Its Analogues from the Marine Sponge <i>Geodia barretti</i>: Progress and Perspectives.

Marine drugs·2026

Same author

Pharmacological and Medicinal Properties of the South American Medicinal Plant <i>Bowdichia virgilioides</i> Kunth and Its Bioactive Products.

Life (Basel, Switzerland)·2026

This review details second-generation camptothecin derivatives, including lurtotecan and exatecan, as advanced topoisomerase I inhibitors for cancer therapy. Future prospects include novel homocamptothecins like diflomotecan for enhanced anticancer efficacy.

Area of Science:

Pharmacology and Oncology
Medicinal Chemistry

Background:

Cancer treatment relies on effective chemotherapeutic agents.
Camptothecin derivatives are crucial topoisomerase I inhibitors in cancer therapy.
Established drugs like topotecan and irinotecan have clinical use.

Purpose of the Study:

To review the molecular characteristics of second-generation camptothecin derivatives.
To explore emerging camptothecin analogues and their therapeutic potential.
To discuss the future of camptothecin-based anticancer drugs.

Main Methods:

Literature review of camptothecin derivatives.
Analysis of molecular properties of novel analogues.
Discussion of preclinical and clinical data for emerging drugs.

Related Experiment Videos

Main Results:

Detailed presentation of second-generation camptothecins: lurtotecan, exatecan, rubitecan, and silatecan.
Identification of homocamptothecins and diflomotecan as promising future anticancer agents.
Overview of modified lactone ring camptothecin derivatives.

Conclusions:

Second-generation camptothecins offer expanded options for topoisomerase I inhibition.
Novel derivatives like diflomotecan show significant anticancer promise.
Continued research into camptothecin analogues is vital for advancing cancer treatment.